Published in Am Rev Respir Dis on August 01, 1986
Central sleep apnea: Pathophysiology and treatment. Chest (2007) 2.59
Improvement of idiopathic central sleep apnea with zolpidem. J Clin Sleep Med (2009) 1.06
Classification of sleep disorders. Neurotherapeutics (2012) 0.97
Inactivity-induced respiratory plasticity: protecting the drive to breathe in disorders that reduce respiratory neural activity. Respir Physiol Neurobiol (2013) 0.86
Central sleep apnoea-a clinical review. J Thorac Dis (2015) 0.80
Sleep disordered breathing and its treatment in congestive heart failure. Heart (2005) 0.79
Treatment of the obstructive sleep apnea syndrome. West J Med (1987) 0.75
Sleep-related breathing disorders. 7. Sleep and breathing problems in general medicine. Thorax (1995) 0.75
Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med (1999) 4.09
Effect of low concentrations of ozone on inhaled allergen responses in asthmatic subjects. Lancet (1991) 3.92
Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest (1997) 3.51
High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens (2001) 2.95
Do patients with obstructive sleep apnea have thick necks? Am Rev Respir Dis (1990) 2.89
Results of single-lung transplantation for bilateral pulmonary fibrosis. The Toronto Lung Transplant Group. N Engl J Med (1990) 2.85
Control of breathing during sleep. Am Rev Respir Dis (1978) 2.78
Role of hyperventilation in the pathogenesis of central sleep apneas in patients with congestive heart failure. Am Rev Respir Dis (1993) 2.61
Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation (2000) 2.29
Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med (2001) 2.08
Airflow limitation in morbidly obese, nonsmoking men. Ann Intern Med (1990) 2.06
Sleep apnea--a major public health problem. N Engl J Med (1993) 2.02
Pharyngeal size in snorers, nonsnorers, and patients with obstructive sleep apnea. N Engl J Med (1986) 1.94
Mechanisms of cell death after pancreatic duct obstruction in the opossum and the rat. Gastroenterology (1996) 1.94
Limited contribution of emphysema in advanced chronic obstructive pulmonary disease. Am Rev Respir Dis (1993) 1.93
Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients. Chest (2001) 1.92
Predictive value of clinical features for the obstructive sleep apnoea syndrome. Eur Respir J (1996) 1.91
Effect of supplemental nocturnal oxygen on gas exchange in patients with severe obstructive lung disease. N Engl J Med (1984) 1.88
Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. Am J Respir Crit Care Med (1997) 1.86
Pathophysiology of obstructive sleep apnoea. Eur Respir J (1995) 1.85
Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. Eur Respir J (2000) 1.80
Reversible hypercapnia in chronic obstructive pulmonary disease: a distinct pattern of respiratory failure with a favorable prognosis. Am J Med (1997) 1.76
The long-term pulmonary sequelae of prematurity: the role of familial airway hyperreactivity and the respiratory distress syndrome. N Engl J Med (1985) 1.76
Hypoxaemia during chest physiotherapy in patients with cystic fibrosis. Ir J Med Sci (1986) 1.74
Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med (1995) 1.70
Regulation of the Mycobacterium tuberculosis PE/PPE genes. Tuberculosis (Edinb) (2004) 1.67
The physiologic basis of training patients with emphysema. Am Rev Respir Dis (1967) 1.67
Evaluation and performance standards for arterial prostheses. J Vasc Surg (1993) 1.64
Reverse arterial blood flow as a pathway for central nervous system toxic responses following injection of local anesthetics. Anesth Analg (1978) 1.63
A new ventilator for monitoring lung mechanics in small animals. J Appl Physiol (1985) (2000) 1.63
Management of obstructive sleep apnea in Europe. Sleep Med (2010) 1.56
Lung volume dependence of pharyngeal cross-sectional area in patients with obstructive sleep apnea. Am Rev Respir Dis (1984) 1.55
Volume of isoflow. A new test in detection of mild abnormalities of lung mechanics. Am Rev Respir Dis (1974) 1.53
Continuous positive airway pressure increases heart rate variability in congestive heart failure. J Am Coll Cardiol (1995) 1.51
Effect of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure. Circulation (1995) 1.49
Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation (1998) 1.48
Accidental exposure to freezing: clinical and laboratory observations during convalescence from near-fatal hypothermia. Can Med Assoc J (1967) 1.47
Long term treatment of refractory congestive heart failure by continuous positive airway pressure. Can J Cardiol (1999) 1.46
Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax (2009) 1.45
Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J (2009) 1.43
Cycle length of periodic breathing in patients with and without heart failure. Am J Respir Crit Care Med (1996) 1.43
Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. Thorax (2005) 1.42
The treatment of obstructive sleep apnea--who, when, how? West J Med (1987) 1.39
A predicted operon map for Mycobacterium tuberculosis. Nucleic Acids Res (2007) 1.39
Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy. Chest (2000) 1.35
Simplified diagnosis of small-airway obstruction. N Engl J Med (1973) 1.34
Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. Lancet (1991) 1.32
Clinical, genetic, and epidemiological factors in neural tube defects. Am J Hum Genet (1988) 1.31
Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. Am J Respir Crit Care Med (1995) 1.30
Relationship between sleep apnoea and mortality in patients with ischaemic heart failure. Heart (2009) 1.30
Arousal: the forgotten response to respiratory stimuli. Am Rev Respir Dis (1978) 1.28
Exhaled nitric oxide after beta2-agonist inhalation and spirometry in asthma. Am J Respir Crit Care Med (1999) 1.28
Regulation of respiration in sleeping dogs. J Appl Physiol (1976) 1.27
Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J (2003) 1.26
The effects of air pollution on allergic bronchial responsiveness. Clin Exp Allergy (1992) 1.26
Upper airway morphology in patients with idiopathic obstructive sleep apnea. Am Rev Respir Dis (1984) 1.26
Effect of nasal continuous positive airway pressure on sleep apnea in congestive heart failure. Am Rev Respir Dis (1989) 1.25
Overnight shift from obstructive to central apneas in patients with heart failure: role of PCO2 and circulatory delay. Circulation (2001) 1.24
Interaction of hyperventilation and arousal in the pathogenesis of idiopathic central sleep apnea. Am J Respir Crit Care Med (1994) 1.23
Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis (1985) 1.22
Haemodynamic effects of continuous positive airway pressure in humans with normal and impaired left ventricular function. Clin Sci (Lond) (1995) 1.22
Reciprocal tonic activation of inspiratory and expiratory motoneurones by chemical drives. Nature (1982) 1.21
Canine model of obstructive sleep apnea: model description and preliminary application. J Appl Physiol (1985) (1994) 1.19
Contribution of emphysema and small airways in COPD. Chest (1996) 1.19
Airway nitric oxide diffusion in asthma: Role in pulmonary function and bronchial responsiveness. Am J Respir Crit Care Med (2000) 1.19
Obstructive apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis (1982) 1.18
Immediate effects of arousal from sleep on cardiac autonomic outflow in the absence of breathing in dogs. J Appl Physiol (1985) (1995) 1.18
Physiological determinants of nocturnal arterial oxygenation in patients with obstructive sleep apnea. J Appl Physiol (1985) (1985) 1.18
Effect of vagal blockade on regulation of breathing in conscious dogs. J Appl Physiol (1970) 1.18
Effect of ketosis on respiratory sensitivity to carbon dioxide in obesity. N Engl J Med (1976) 1.16
Relationship of carbon dioxide tension in arterial blood to pulmonary wedge pressure in heart failure. Eur Respir J (2002) 1.16
Pathogenesis and pathophysiology of the obstructive sleep apnea syndrome. Med Clin North Am (1985) 1.15
The DosR regulon of M. tuberculosis and antibacterial tolerance. Tuberculosis (Edinb) (2009) 1.15
Critical dependence of respiratory rhythmicity on metabolic CO2 load. J Appl Physiol Respir Environ Exerc Physiol (1981) 1.15
Waking and ventilatory responses to laryngeal stimulation in sleeping dogs. J Appl Physiol Respir Environ Exerc Physiol (1978) 1.15
Public health and medicolegal implications of sleep apnoea. Eur Respir J (2002) 1.14
Is sleep apnoea more common in North America? Lancet (1982) 1.14